Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Verona Pharma plc - American Depositary Shares (NQ:VRNA)

106.91 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Verona Pharma plc - American Depositary Shares

< Previous 1 2 3 4 5 Next >
News headline image
4 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Is Verona Pharma Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Oracle To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today ↗
Via The Motley Fool
News headline image
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data ↗
Regeneron and Sanofi's COPD drug itepekimab cut exacerbations by 27% in one Phase 3 trial, while the second trial did not meet its main goal. 
Via Benzinga
News headline image
Earnings Scheduled For April 29, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Earnings Preview For Verona Pharma ↗
 
Via Benzinga
News headline image
Jim Cramer Says This Quantum Computing Stock Is 'So High' And 'Too Speculative' ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 22% This Week ↗
The company is working to launch its COPD treatment more broadly. The drug is a non-steroidal nebulizer. 
Via Investor's Business Daily
News headline image
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent ↗
The FDA signed off on Regeneron and Sanofi's Dupixent for patients with uncontrolled COPD. 
Via Investor's Business Daily
News headline image
Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug ↗
GSK's Phase 3 MATINEE trial of Nucala in COPD met the primary endpoint, reducing exacerbations significantly over 104 weeks. 
Via Benzinga
News headline image
Top 3 Health Care Stocks That May Crash In August ↗
 
Via Benzinga
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
VRNA Stock Earnings: Verona Pharma Misses EPS for Q2 2024 ↗
VRNA stock results show that Verona Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Top 3 Health Care Stocks You May Want To Dump This Quarter ↗
 
Via Benzinga
News headline image
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product ↗
The FDA has approved Verona Pharma's Ohtuvayre (ensifentrine) as maintenance treatment of chronic obstructive pulmonary disease in adults. The drug could generate $3.6 billion in peak sales. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
Via Benzinga
News headline image
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks ↗
The companies are closing in on the finish line for two new COPD treatments. 
Via Investor's Business Daily
News headline image
VRNA Stock Earnings: Verona Pharma Misses EPS for Q1 2024 ↗
VRNA stock results show that Verona Pharma missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022 ↗
The healthcare sector is no slouch when it comes to top-performing growth stocks. 
Via The Motley Fool
News headline image
3 Stocks That Could Be Monster Winners in 2024 ↗
Don't be surprised if these three stocks take off in the new year. 
Via The Motley Fool
News headline image
Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves ↗
In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion... 
Via Benzinga
News headline image
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.